Seguir
Jana Tchekalarova
Jana Tchekalarova
Institute of Neurobiology Bulgarian Academy of Sciences
Dirección de correo verificada de inb.bas.bg
Título
Citado por
Citado por
Año
Effect of long-term caffeine administration on depressive-like behavior in rats exposed to chronic unpredictable stress
DM Pechlivanova, JD Tchekalarova, LH Alova, VV Petkov, RP Nikolov, ...
Behavioural pharmacology 23 (4), 339-347, 2012
722012
Recent developments of hydrazide/hydrazone derivatives and their analogs as anticonvulsant agents in animal models
V Angelova, V Karabeliov, PA Andreeva‐Gateva, J Tchekalarova
Drug development research 77 (7), 379-392, 2016
682016
Dose-dependent effects of caffeine on behavior and thermoregulation in a chronic unpredictable stress model of depression in rats
D Pechlivanova, J Tchekalarova, R Nikolov, K Yakimova
Behavioural brain research 209 (2), 205-211, 2010
662010
Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?
J Tchekalarova, V Georgiev
Life sciences 76 (9), 955-970, 2005
652005
Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light
J Tchekalarova, T Stoynova, K Ilieva, R Mitreva, M Atanasova
Pharmacology biochemistry and behavior 171, 1-9, 2018
632018
Prophylactic treatment with melatonin after status epilepticus: Effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy
J Tchekalarova, Z Petkova, D Pechlivanova, S Moyanova, L Kortenska, ...
Epilepsy & Behavior 27 (1), 174-187, 2013
622013
Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy
JD Tchekalarova, NM Ivanova, DM Pechlivanova, D Atanasova, ...
Pharmacology Biochemistry and Behavior 127, 27-36, 2014
552014
Diurnal variations in depression-like behavior of Wistar and spontaneously hypertensive rats in the kainate model of temporal lobe epilepsy
J Tchekalarova, D Pechlivanova, T Atanasova, P Markova, V Lozanov, ...
Epilepsy & Behavior 20 (2), 277-285, 2011
552011
Postnatal caffeine exposure: effects on motor skills and locomotor activity during ontogenesis
J Tchekalarova, H Kubova, P Mareš
Behavioural brain research 160 (1), 99-106, 2005
502005
Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral …
Z Petkova, J Tchekalarova, D Pechlivanova, S Moyanova, L Kortenska, ...
Epilepsy & Behavior 31, 198-208, 2014
492014
Diurnal rhythms of spontaneous recurrent seizures and behavioral alterations of Wistar and spontaneously hypertensive rats in the kainate model of epilepsy
J Tchekalarova, D Pechlivanova, D Itzev, N Lazarov, P Markova, ...
Epilepsy & Behavior 17 (1), 23-32, 2010
472010
Long-term treatment with losartan attenuates seizure activity and neuronal damage without affecting behavioral changes in a model of co-morbid hypertension and epilepsy
JD Tchekalarova, N Ivanova, D Atanasova, DM Pechlivanova, N Lazarov, ...
Cellular and molecular neurobiology 36, 927-941, 2016
422016
Consequences of long-term treatment with agomelatine on depressive-like behavior and neurobiological abnormalities in pinealectomized rats
J Tchekalarova, Z Nenchovska, D Atanasova, M Atanasova, L Kortenska, ...
Behavioural brain research 302, 11-28, 2016
402016
Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy
J Tchekalarova, D Atanasova, Z Nenchovska, M Atanasova, L Kortenska, ...
Neurobiology of Disease 104, 1-14, 2017
382017
Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: effects of angiotensin IV
J Tchekalarova, E Sotiriou, V Georgiev, G Kostopoulos, F Angelatou
Brain research 1032 (1-2), 94-103, 2005
382005
Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice
J Tchekalarova, K da Conceição Machado, ALG Júnior, ...
Seizure 57, 22-26, 2018
342018
Oxidative stress and aging as risk factors for Alzheimer’s disease and Parkinson’s disease: the role of the antioxidant melatonin
J Tchekalarova, R Tzoneva
International Journal of Molecular Sciences 24 (3), 3022, 2023
322023
Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels
J Tchekalarova, D Albrecht
Neuroscience letters 415 (1), 68-72, 2007
312007
The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception
J Tchekalarova, D Pechlivanova, T Kambourova, J Matsoukas, ...
Regulatory peptides 111 (1-3), 191-197, 2003
312003
Chronic agomelatine treatment prevents comorbid depression in the post-status epilepticus model of acquired epilepsy through suppression of inflammatory signaling
J Tchekalarova, D Atanasova, L Kortenska, M Atanasova, N Lazarov
Neurobiology of Disease 115, 127-144, 2018
302018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20